← 產業報告目錄
De-identified Health Data Market, Share & Trends Analysis Report, By Type of Data (Clinical, Genomic and Others), By End-use (Pharmaceutical Companies, Biotechnology Firms and Others), By Application, By Region, and Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-31頁數 165報告編號 INSIGHTACE-ed3b41c85b
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The De-identified Health Data Market on a global scale was estimated at USD 7.29 Bn in 2023 and is forecasted to attain USD 13.77 Bn by 2031, with a projected CAGR of 8.5% between 2024 and 2031.
At its core, De-identified Health Data pertains to an organizational method used to eliminate personal information from data that is gathered, utilized, stored, and shared with other organizations. Stakeholders across the healthcare landscape are mountingly turning to these solutions to meet contemporary demands.
Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global De-identified Health Data Market Snapshot
Chapter 4. Global De-identified Health Data Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global De-identified Health Data Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on De-identified Health Data Industry Trends
Chapter 5. De-identified Health Data Market Segmentation 1: By Type of Data, Estimates & Trend Analysis
5.1. Market Share by By Type of Data, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type of Data:
5.2.1. Clinical Data
5.2.2. Genomic Data
5.2.3. Patient Demographics
5.2.4. Prescription Data
5.2.5. Claims Data
5.2.6. Behavioral Data
5.2.7. Wearable and Sensor Data
5.2.8. Survey and Patient-Reported Data
5.2.9. Imaging Data
5.2.10. Laboratory Data
5.2.11. Hospital and Provider Data
5.2.12. Social Determinants of Health (SDoH) Data
5.2.13. Pharmacogenomic Data
5.2.14. Biometric Data
5.2.15. Operational and Financial Data
5.2.16. Epidemiological Data
5.2.17. Healthcare Utilization Data
5.2.18. Others
Chapter 6. De-identified Health Data Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Applications:
6.2.1. Clinical Research and Trials
6.2.2. Public Health
6.2.3. Precision Medicine
6.2.4. Health Economics and Outcomes Research (HEOR)
6.2.5. Population Health Management
6.2.6. Drug Discovery and Development
6.2.7. Healthcare Quality Improvement
6.2.8. Insurance Underwriting and Risk Assessment
6.2.9. Market Access and Commercial Strategy
6.2.10. Business Intelligence and Operational Efficiency
6.2.11. Telemedicine and Remote Monitoring
6.2.12. Patient Engagement and Support Programs
6.2.13. Others
Chapter 7. De-identified Health Data Market Segmentation 3: By End user, Estimates & Trend Analysis
7.1. Market Share by End user, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End users:
7.2.1. Pharmaceutical Companies
7.2.2. Biotechnology Firms
7.2.3. Medical Device Manufacturers
7.2.4. Healthcare Providers
7.2.5. Insurance Companies/ Healthcare Payers
7.2.6. Research Institutions
7.2.7. Government Agencies
7.2.8. Others
Chapter 8. De-identified Health Data Market Segmentation 6: Regional Estimates & Trend Analysis
8.1. Global De-identified Health Data Market, Regional Snapshot 2023 & 2031
8.2. North America
8.2.1. North America De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by By Type of Data, 2024-2031
8.2.3. North America De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. North America De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031
8.3. Europe
8.3.1. Europe De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by By Type of Data, 2024-2031
8.3.3. Europe De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Europe De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031
8.4. Asia Pacific
8.4.1. Asia Pacific De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by By Type of Data, 2024-2031
8.4.3. Asia Pacific De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.4. Asia Pacific De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts By End user, 2024-2031
8.5. Latin America
8.5.1. Latin America De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by By Type of Data, 2024-2031
8.5.3. Latin America De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Latin America De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031
8.6. Middle East & Africa
8.6.1. Middle East & Africa De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by By Type of Data, 2024-2031
8.6.3. Middle East & Africa De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by application, 2024-2031
8.6.4. Middle East & Africa De-identified Health Data Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. IQVIA
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Offerings
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Oracle
9.2.3. Merative
9.2.4. Optum, Inc.
9.2.5. ICON plc
9.2.6. Veradigm LLC
9.2.7. IBM
9.2.8. Flatiron Health
9.2.9. Premier, Inc.
9.2.10. Shaip
9.2.11. Komodo Health, Inc.
9.2.12. Evidation Health, Inc.
9.2.13. Medidata
9.2.14. Clarify Health Solutions
9.2.15. Satori Cyber Ltd.
9.2.16. Kitware
9.2.17. BioData Consortium
9.2.18. Akrivia Health
9.2.19. iMerit
9.2.20. Other Market Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們